A detailed history of Merriman Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Merriman Wealth Management, LLC holds 3,291 shares of ABBV stock, worth $560,621. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,291
Previous 3,287 0.12%
Holding current value
$560,621
Previous $563,000 15.28%
% of portfolio
0.03%
Previous 0.03%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$163.84 - $199.33 $655 - $797
4 Added 0.12%
3,291 $649,000
Q2 2024

Aug 13, 2024

SELL
$154.79 - $180.76 $3,714 - $4,338
-24 Reduced 0.72%
3,287 $563,000
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $639 - $728
4 Added 0.12%
3,311 $602,000
Q4 2023

Feb 13, 2024

BUY
$137.6 - $154.97 $13,760 - $15,497
100 Added 3.12%
3,307 $512,000
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $6,360 - $7,915
-48 Reduced 1.47%
3,207 $432,000
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $15,629 - $18,743
113 Added 3.6%
3,255 $526,000
Q3 2022

Oct 26, 2022

BUY
$134.21 - $153.93 $5,502 - $6,311
41 Added 1.32%
3,142 $422,000
Q2 2022

Jul 29, 2022

SELL
$137.62 - $174.96 $4,266 - $5,423
-31 Reduced 0.99%
3,101 $474,000
Q1 2022

Apr 28, 2022

SELL
$131.98 - $163.75 $46,193 - $57,312
-350 Reduced 10.05%
3,132 $508,000
Q4 2021

Feb 01, 2022

BUY
$107.43 - $135.93 $966 - $1,223
9 Added 0.3%
3,022 $340,000
Q4 2021

Feb 01, 2022

BUY
$107.43 - $135.93 $49,417 - $62,527
460 Added 15.22%
3,482 $471,000
Q3 2021

Nov 09, 2021

SELL
$106.4 - $120.78 $957 - $1,087
-9 Reduced 0.3%
3,013 $325,000
Q2 2021

Jul 28, 2021

BUY
$105.21 - $117.21 $15,255 - $16,995
145 Added 5.04%
3,022 $340,000
Q1 2021

May 10, 2021

SELL
$102.3 - $112.62 $97,491 - $107,326
-953 Reduced 24.88%
2,877 $311,000
Q4 2020

Feb 10, 2021

BUY
$80.49 - $108.67 $308,276 - $416,206
3,830 New
3,830 $411,000
Q3 2020

Oct 26, 2020

SELL
$85.91 - $100.83 $202,919 - $238,160
-2,362 Closed
0 $0
Q2 2020

Jul 31, 2020

SELL
$73.37 - $98.18 $27,220 - $36,424
-371 Reduced 13.57%
2,362 $232,000
Q1 2020

Apr 22, 2020

SELL
$64.5 - $97.79 $22,897 - $34,715
-355 Reduced 11.5%
2,733 $208,000
Q4 2019

Jan 23, 2020

BUY
$72.13 - $90.25 $222,737 - $278,692
3,088 New
3,088 $273,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Merriman Wealth Management, LLC Portfolio

Follow Merriman Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Merriman Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Merriman Wealth Management, LLC with notifications on news.